PPARG and lipodystrophy: Targeted deletion of PPARγ in adipose tissue had been found to result in lipodystrophy or no visible adipose tissue, dyslipidaemia and adipokine deregulation, and extreme insulin resistance (He et al., 2003; Jones et al., 2005; Wang et al., 2013).